TruScreen Group Limited reported that the Dr Sulaiman Al-Habib Medical Group, has installed the first tranche of four TruScreen devices for commercial use, for the screening of cervical cancer in Saudi Arabia. The adoption of TruScreen's screening technology by DSAMG private hospitals will be important reference sites for further market access in neighbouring Middle Eastern nations. This installation follows from the previously announced successful completion of the clinical evaluation by DSAMG network, followed by a successful tender by BettaLife Trading FZC (BettaLife) (Truescreen's distributor in the Middle East).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.017 NZD | 0.00% | -10.53% | -26.09% |
13/03 | Truscreen Group Raises Additional NZ$520,000 via Share Placement; Shares Jump 5% | MT |
08/03 | New Zealand Shares Jump on Friday, Fisher & Paykel Healthcare's Chair to Retire | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.09% | 5.65M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
+0.61% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- TRU Stock
- News TruScreen Group Limited
- TruScreen Group Limited Announces Dr Sulaiman Al-Habib Medical Group Installs First Tranche of Four TruScreen Devices for Commercial Use, for Screening of Cervical Cancer in Saudi Arabia